Sialylated glycoprotein composition and uses thereof
OwnerSteven JUNGLES, Gabrielle MORRIS +3inventors
InventorsSteven JUNGLES, Gabrielle MORRIS, Jeff GRUBB, Michael VELLARD, Emil D. KAKKIS
Life of this patent
Estimating the term…
Abstract
The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.
Claims14
1-27. (canceled)
A composition comprising a recombinant glycoprotein, wherein the recombinant glycoprotein is human β-glucuronidase and has a sialylation content of at least 0.7 mol/mol of the recombinant glycoprotein.
A preparation of a population of a recombinant glycoprotein, wherein the recombinant protein is human β-glucuronidase and wherein at least 10% percentage of the population of the recombinant glycoprotein is sialylated.
A method for treating a condition or disorder in a subject, comprising administering to the subject a regimen comprising a recombinant glycoprotein that has a sialylation content of at least 0.7 mol/mol of the recombinant glycoprotein, wherein the administration provides a statistically significant therapeutic effect for the treatment of the condition or disorder.
Dependencies are inferred from the claim text.